Split-System Chlorella Biorefinery Pilot

Executive Summary

Investment-Grade Brief

What's new in Public Edition v1.1 — Independent Scientific Review Response

This Public Edition has been revised in response to an independent line-by-line scientific review of v1.0. The technical and commercial architecture of the pilot is unchanged. Substantive edits include:

Cell-wall biochemistry corrected to Chlorella vulgaris-specific chitin/glucosamine matrix description.
Omega-3 profile clarified — dominant native omega-3 of C. vulgaris is α-linolenic acid (ALA), not EPA; EPA route is treated as a Phase-2 R&D path.
Sulphated polysaccharides — strain-specificity caveat added; in-scope CGF stream reframed as β-glucan / mixed polysaccharide.
B100 standby-genset CO₂ recovery — clarified as a Phase-2 capex item; Phase-1 vents biogenic CO₂ and credits it to the renewable-fuel cycle.
Market sizing updated — CGF revised to USD 410 M; algal/plant peptide segment held at ₱640 M with the broader ~USD 2.5 B total-peptide context disclosed; algal omega-3 revised to USD 1,040 M.
"345 productive days" definition disclosed.
Revenue-uplift logic for the Year-3 commercial scenario disclosed in transparent layered form.
ICH Q3C residual-solvent limits — specific per-solvent limits disclosed (ethanol ≤ 5,000 ppm; hexane ≤ 290 ppm).
Asset-valuation construction basis — disclosed as sponsor-managed pilot-grade local construction.
Phase-2 Azolla N mass-balance — transparent calculation supersedes earlier indicative footprint figure.

Forward-looking expansion capex figures in this Public Edition should be interpreted with a 20–30% contingency band typical of pilot-to-commercial scale-up.

This pilot Split-System Chlorella Biorefinery in Pampanga uses a two-stage architecture: (1) low-cost outdoor cultivation in 16 concrete cylindrical tanks (Ø 6 m × 1 m; ≈ 452 m² total culture area) to generate bulk Chlorella vulgaris biomass on natural Philippine sunlight, and (2) indoor stress-induction in 20 fiberglass pools (3 m × 1.8 m × 0.77 m; 108 m² total) where controlled stress modalities redirect cellular metabolism into five high-value metabolite streams before downstream extraction.

The pilot has already demonstrated, in twelve months of operation:

Outdoor productivity of 12.9 g·m⁻²·d⁻¹ averaged over 12 months — 92% of the TEA design value of 14 g·m⁻²·d⁻¹ (steady-state months 13.7 g·m⁻²·d⁻¹, within 2% of design); cumulative dry biomass 2,011 kg vs. design 2,300 kg.
Indoor stress batches achieving 87–91% of targeted concentrations across five metabolite classes (lutein, chlorophyll a+b, polysaccharides/CGF, peptides, omega-3 fatty acids), with Q3–Q4 batches converging on TEA design as stress recipes were refined.
Robust operations: 345 productive days (defined as days with at least one tank harvest, transfer or active stress run; the 20 non-productive days comprise the 5-day typhoon shutdown plus 15 days of scheduled maintenance, partial-shift turnover and 2 short contamination clean-downs), 3 localised contamination events fully contained without batch loss, zero major equipment failures.

The next-stage commercial expansion completes the downstream processing line, analytical lab, regulatory pathway, and 12 months of working capital required to convert this technical success into scalable cash flow — anchored on a verified ₱17.1M in deployed sponsor equity covering tanks, pools, two biomass gasifiers, the Hydrodynamic Cavitator Unit, and the B100-biodiesel-fuelled standby genset.

Outdoor Capacity

16 Tanks

Ø6 m × 1 m · 452 m²

Indoor Pools

20 Units

108 m² · LED stress

Biomass Yield

2,011 kg

12.9 g·m⁻²·d⁻¹ avg

Pilot Asset Base

₱17.1M

Year-3 Revenue ₱27.7M

Actionability for the Split-System Business Model

This pilot configuration and the measured data constitute an operational template that can be replicated or licensed to other Philippine sites (e.g. a Phase 2 expansion of 2–5 ha), with the Pampanga plant serving as proof-of-concept, training hub, and regulatory anchor.

The Split-System Business Model

Grow Cheap · Enrich Expensive

The Split-System Business Model is deliberately simple and is articulated as “grow cheap, enrich expensive.” Outdoor tanks act as the “farm” producing low-cost biomass, while indoor pools act as precision bioreactors that concentrate specific, high-margin metabolites under controlled stress. The two stages are physically and operationally decoupled, which lets the project place capital, energy, and labour exactly where the marginal return justifies it.

Stage 1 — Outdoor Bulk Cultivation (Low Cost)

Sixteen Ø 6 m × 1 m cylindrical tanks (~452 m²) positioned outdoors, harvesting Philippine solar irradiance year-round.
Chlorella vulgaris grown on minimal inputs: water (purified through the on-site Hydrodynamic Cavitator Unit), modest N/P fertiliser, and biogenic CO₂ from the two biomass gasifiers and the B100-biodiesel-fuelled standby genset.
Electricity-intensive artificial lighting and air-conditioning are entirely avoided at this stage; measured biomass cost is ~₱112–168/kg dry.
Pilot data confirm annual production near 2,300 kg dry biomass under normal operations (2,011 kg actual during the first 12 months, including a 5-day typhoon shutdown in Month 7).

Stage 2 — Indoor Stress-Induction (High Value)

Approximately 70% of outdoor biomass (~1,600 kg/y) is centrifuged, washed, and re-inoculated into the 20 indoor pools (3 m × 1.8 m × 0.77 m; 108 m² total).
Indoor pools do not grow new biomass. They re-suspend already-grown cells in fresh stress-formulated medium and impose controlled stimuli (light, nutrient, temperature, salinity) to redirect carbon flux into target molecules.
The remaining 30% (~700 kg/y) bypasses stress and is spray-dried as bulk Chlorella powder (~₱1,000/kg) for tablet, food-fortification, and aquaculture markets.

Two Revenue Tiers

Base (Domestic Commodity): standard-grade extracts and bulk powder distributed locally — a ~₱10.25M portfolio that is realisable from Day 1 with minimal regulatory friction.
Premium (Export & B2B): the same physical products at FDA-registered, halal-certified, contract-backed international benchmark prices — the primary driver of the Year-3 ₱27.7M revenue line.

Reconciling 2,011 kg → ₱10.25M → ₱27.7M (Transparent Revenue Bridge)

Year-1 pilot biomass of 2,011 kg cannot, on its own, generate the ₱10.25M base portfolio at the indicative metabolite concentrations — a point correctly identified in independent third-party review. The figures are not a Year-1 pilot revenue claim; they are a Year-3 commercial throughput projection built on five disclosed layers:

Layer 1 — Conservative base (₱10.25M): uses the audited TEA model output at 100% facility capacity (≈ 6,500–7,500 kg/y biomass after the next-stage throughput uplift via indoor pool re-cycling, dual-shift operation and capacity-rated extraction line — i.e. roughly 3–4× the Year-1 measured 2,011 kg) priced at the low end of the global market range and assuming no premium contracts.
Layer 2 — FDA-registered premium uplift (+₱5–7M): registered-product price premium of 30–80% across CGF, peptides and ALA-rich PUFA streams.
Layer 3 — Halal export channel (+₱3–4M): ASEAN halal-certified pricing premium of 40–80%.
Layer 4 — B2B custom-spec contracts (+₱4–5M): LOI-backed bespoke supply (CGF nutraceutical, multi-product halal export).
Layer 5 — Pilot & R&D services (+₱1–2M): contract pilot runs and licensing fees.

Worked example (lutein, conservative Layer-1 only): at 6,500 kg total biomass × 70% to indoor stress (4,550 kg) × 0.27% lutein DW = 12.3 kg lutein × USD 1,000/kg ≈ ₱690k from a single stream; the full five-stream extract portfolio plus bulk powder yields the ₱10.25M figure. The ₱27.7M Year-3 line then layers FDA, halal, B2B and R&D revenue on top of the conservative base.

Why the Architecture Matters

Conventional all-indoor photobioreactor (PBR) facilities pay both the capital cost and the energy cost of artificial light for every kilogram of biomass produced. The split-system pays artificial-light costs only for the high-value 70% of biomass after growth has happened — typically reducing cost-per-gram of finished metabolite by 35–55% versus an equivalent all-PBR design while preserving the metabolite yields that justify premium pricing.

The Split-System architecture is therefore the commercial spine of the Pampanga pilot: it couples a proven, low-cost biomass source with a modular “metabolite enrichment and extraction” block, de-risking subsequent scale-up to hectarage operations and licensing deals.

Outdoor Cultivation in 16 Concrete Cylindrical Tanks

Design, Performance & CO₂ Integration

Tank Geometry & Infrastructure

Parameter	Specification	Source
Number of tanks	16 outdoor cylindrical tanks	Existing Assets Register
Dimensions	Ø 6 m × 1 m deep (concrete / HDPE)
Hydraulics	Paddlewheel circulation, 30–60 rpm
Total culture area	≈ 452 m²
Role	Stage 1 — low-cost bulk biomass production

Pilot Productivity — 12-Month Log

The plant has a full year of operating data covering productivity, biomass yield, and reliability.

Month	g·m⁻²·d⁻¹	Dry kg	Key Note
1	9.2	116	Ramp-up, rotifer in Tank 7
2	11.4	149	SOP refinement
3	12.8	174	Stable
4	13.5	171	Maintenance
5	14.1	191	Optimal irradiance
6	13.9	182	Ciliate controlled
7	11.6	131	Typhoon, 5-day shutdown
8	12.3	156	Recovery
9	13.6	178	Stable
10	14.3	194	Best month
11	14.0	183	Stable
12	13.7	186	Year-end audit batch
Avg	12.9	2,011	92% of TEA 14 g·m⁻²·d⁻¹

Steady-state months (3–6, 8–12) averaged 13.7 g·m⁻²·d⁻¹ — within ~2% of TEA design — underscoring the robustness of this outdoor tank design for Pampanga's climate.

CO₂ Supply — The Biogenic Loop (Two Gasifiers + B100 Genset)

Carbon dioxide is delivered through a fully biogenic, two-source loop:

Two on-site downdraft biomass gasifiers (~50–100 kg/h feedstock each) burn agricultural residues — rice husks, coconut shells, wood chips. Syngas is combusted in direct-fire burners; the resulting CO₂-rich flue gas is scrubbed of particulates and injected into outdoor tank diffusers. The dual-gasifier configuration provides redundancy: one unit can be taken offline for maintenance without interrupting CO₂ supply to the sixteen-tank array.
One 150 kVA standby genset, fuelled exclusively on B100 biodiesel, serves as both backup power and a secondary biogenic CO₂ source. The CO₂ molecule itself is identical to that in gasifier flue gas, but B100 combustion exhaust additionally contains NOₓ, residual particulates and trace combustion products that must be removed before cultivation injection. Exhaust is therefore tied into the same wet-scrubber and water-trap train used for gasifier flue gas, and only the scrubbed, conditioned stream is injected into the tanks.

This eliminates purchased industrial CO₂ entirely, aligning the project with national clean-energy and green-finance programmes and providing a credible carbon-accounting story for downstream buyers requiring sustainable-sourcing documentation.

Process Water — The Hydrodynamic Cavitator Unit (HDCU)

Process-water quality is one of the most under-appreciated determinants of tropical open-tank cultivation success. Bacterial and protozoan contaminants in untreated water are a leading cause of culture crashes. The HDCU sits between the water-storage system and the outdoor distribution manifolds and treats every litre of culture water through controlled hydrodynamic cavitation — pressure-induced micro-bubble collapse that mechanically disrupts microbial cell walls and oxidises dissolved organics, with no chemical residue that could inhibit Chlorella growth. The HDCU is a meaningful contributor to the pilot's low recorded contamination rate (3 events / 345 operating days).

Actionable Cultivation Practices (Pilot-Proven)

Maintain culture depth at ~0.25–0.30 m effective depth (within the 1 m tank wall) to optimise photic-zone light penetration while preserving paddlewheel mixing and gas exchange.
Operate paddlewheels at 30–60 rpm to prevent thermal stratification and keep cells in rapid light–dark cycling — empirically the most effective regime for Chlorella in raceway-style geometries.
Monitor pH (target 6.8–7.6), DO, and temperature continuously; respond to contamination events (rotifers, ciliates) with targeted pH-shock or nutrient interventions before resorting to batch destruction.
Implement storm protocols (deploy floating covers, temporarily halt CO₂ injection, reduce paddlewheel speed) during typhoon conditions; Month 7 data confirm full recoverability after a 5-day shutdown.

Indoor Stress-Induction in 20 Pools

Precision Biochemistry Stage

Pool Architecture & Role

Parameter	Specification	Source
Number of pools	20 indoor stress-induction pools	Existing Assets
Dimensions	3 m × 1.8 m × 0.77 m (fiberglass)
Combined area	108 m² (effective light path 30–50 cm)
Mixing	Submerged-paddle / airlift hybrid; gentle (no shear-sensitive cell damage)
Lighting	Programmable multi-channel LED arrays — blue 460 nm, red 660 nm, white 5,500 K — 0–800 µmol·m⁻²·s⁻¹ PAR
Re-inoculation	Centrifuged outdoor concentrate + sterile fresh medium dosing system

Critically, these indoor pools do not grow new biomass. They re-inoculate already-grown outdoor biomass into fresh medium and impose stress stimuli. This separation of growth and stress is the core innovation and the key to the project's cost economics.

Stress Modalities — Detailed Mechanism & Protocol Deep Dive

Each stress modality below is mapped to (i) the metabolite class it preferentially induces, (ii) the underlying biochemical mechanism, (iii) typical pilot operating window, and (iv) the harvest-timing rationale. Stress recipes are applied sequentially or in combination depending on the target product; combination stress recipes (e.g. light + N-starvation) are central to the pilot's lutein and omega-3 trains.

Photo / High-Light Stress · Targets: Lutein, β-carotene, Chlorophyll quality

1. Light Stress (Carotenogenesis Driver)

Cells are stepped from outdoor-equivalent ~250 µmol·m⁻²·s⁻¹ to 500–800 µmol·m⁻²·s⁻¹ PAR using blue-enriched LED spectra (460 nm dominant). Excess photons exceed photosystem turnover capacity, generating reactive oxygen species (ROS). Cells respond by upregulating the carotenoid biosynthesis pathway — phytoene synthase → lycopene → lycopene-ε-cyclase branching toward lutein and zeaxanthin — as photoprotective accessory pigments.

Window: 6–10 day photoperiod ramp; intermittent 14:10 L:D cycle to avoid full photoinhibition. Harvest when carotenoid:chlorophyll ratio peaks (typically Day 7–9), monitored daily by 445/665 nm spectrophotometric ratio.

Nutrient (N or P) Starvation · Targets: Lipids, Polysaccharides (CGF), Omega-3

2. Nutrient Stress (Carbon-Flux Re-Routing)

Nitrogen is withdrawn from the medium by inoculating into N-depleted formulation; the C/N ratio of the medium is shifted from ~10:1 to >50:1. With cell division blocked, fixed carbon is rerouted from amino-acid synthesis into storage molecules — neutral lipids (triacylglycerols), polysaccharides (β-glucans, CGF), and starch. Lipid content can rise from a baseline of ~10% DW to 25–40% DW within 7–14 days. P-starvation (similar protocol with phosphate withdrawal) drives polysaccharide accumulation more selectively.

Window: 10–14 day starvation; harvest before chlorophyll degradation becomes commercially significant (Day 11–13).

Temperature Cycling · Targets: Omega-3 fatty acids (EPA/ALA)

3. Temperature-Cycling Stress (Membrane Remodelling)

Pools are programmed to a diurnal-style cycle of 22 °C night / 30–32 °C day. The cold-leg phase forces cells to remodel membrane lipids to maintain fluidity, upregulating Δ12 and ω3-desaturase enzymes that introduce additional double bonds — increasing the polyunsaturated fatty acid (PUFA) fraction, particularly α-linolenic and eicosapentaenoic acids. The warm-leg phase prevents growth arrest and sustains metabolic activity.

Window: 7–10 day cycle; harvest at end of a cold-leg phase to capture peak unsaturated-lipid composition.

Salinity Stress · Targets: Sulphated polysaccharides, peptides, osmoprotectants

4. Salinity / Osmotic Stress (Osmoprotectant Accumulation)

NaCl is dosed into the pool to step from baseline freshwater (0.05% NaCl) to 1.0–2.0% NaCl over 24–48 h. Cells respond to the osmotic challenge by accumulating compatible solutes (glycerol, proline) and by enriching the extractable polysaccharide and peptide fractions, including a modest increase in sulphated polysaccharide moieties. Strain caveat: potent sulphated-polysaccharide bioactivity (immune-modulating, antiviral) is more strongly documented for Dunaliella, Porphyridium and red macroalgae than for C. vulgaris; the salinity-stress yield uplift in the pilot is principally a polysaccharide and peptide enrichment, with strain-specific bioactivity to be confirmed in pilot assay batches before any health-claim language is adopted.

Window: 5–7 day exposure; longer exposures cause irreversible viability loss. Recovery medium washes are required pre-harvest to remove free salt.

Combination · Sequential Stress Recipes

5. Combination Recipes (Sequential Stress)

The pilot's highest-margin batches use carefully sequenced combinations rather than any single modality. Two examples in routine pilot use:

Lutein-rich recipe: 4 days N-starvation (slows division, up-regulates plastid biogenesis) → 6 days high-light blue-enriched stress → harvest. Lifts lutein content from ~0.18% to 0.27% DW.
Omega-3 recipe: 5 days temperature cycling → 4 days mild N-limitation → harvest at cold-leg endpoint. Lifts total ω-3 PUFA (predominantly α-linolenic acid, ALA 18:3) from 2.8% to 4.8% DW. Strain note: C. vulgaris is an ALA-rich species and does not produce significant EPA (20:5) or DHA (22:6); buyers requiring marine-grade EPA/DHA are served by separate Schizochytrium or Nannochloropsis lines outside this pilot's scope.

Process Analytics · Daily / Per-Batch

6. In-Process Monitoring

Each stress batch is tracked daily using:

Chlorophyll fluorescence (Fv/Fm) — primary indicator of photosynthetic stress level; target window varies by recipe.
OD₆₈₀ & OD₇₅₀ — biomass and pigment proxy.
Dry weight (filter-disc, 105 °C) every 48 h for lipid/polysaccharide loading curves.
Microscopy for purity (target <1% non-Chlorella cells).
Endpoint HPLC / GC-FID assay before harvest release.

Metabolite Outcomes — Pilot Assays (ITDI–DOST)

Metabolite	Avg % DW	TEA Target	Achieved
Lutein	0.27	0.30	90%
Chlorophyll a+b	1.09	1.20	91%
Polysaccharides (CGF)	10.5	12.0	88%
Peptides	16.1	18.0	89%
Omega-3 fatty acids	4.8	5.5	87%

Quarterly stress batches, analysed by HPLC (pigments, peptides) and GC-FID (fatty acids), show close convergence to TEA design values, with Q3–Q4 approaching target as stress-recipe parameters were progressively tightened.

Operational Implication

By shipping only 70% of biomass through stress and extraction, and selling 30% as bulk powder, the plant achieves multi-tiered revenue and risk diversification while concentrating indoor energy and capital intensity on the molecules with the highest ₱-per-kg margin. Each pool can run any of the recipes above on a 5–14 day cycle; a typical week sees 2–3 pools in lutein cycle, 3–4 in CGF/lipid cycle, 2 in omega-3 cycle, and the remainder in cleaning/recovery rotation.

Cultivation Propagation & Inoculation Logic

From Cell Bank to Production Tank to Stress Pool

The propagation and inoculation strategy is the “quiet” backbone of the entire Split-System: it determines genetic stability, batch reproducibility, contamination resilience, and ultimately the predictability of metabolite yields. The strategy has been built to satisfy both the pilot HACCP plan (CCP1: re-inoculation) and the eventual GMP pathway needed for FDA-registered products.

Strain Bank & Master Cell-Line Management Tier 0

Master Cell Bank (MCB): the original certified Chlorella vulgaris strain is maintained as cryopreserved ampoules in 10% DMSO at −80 °C, with redundant storage in a separate building. Each ampoule is a 1 mL aliquot from a single qualified culture; the MCB is never thawed for production directly.
Working Cell Bank (WCB): derived from a single thawed MCB ampoule grown out and re-aliquoted into ~50 working ampoules, each able to seed a full propagation cascade. WCBs are renewed annually from the MCB.
Genetic-stability QC: annual ITS sequencing and morphology check confirm strain identity and rule out drift; pigment-profile fingerprint (HPLC) confirms phenotype stability.
Biosafety: the strain is non-toxigenic, non-pathogenic, and formally identified — required for any food-grade FDA registration.

Scale-Up Cascade Tier 1 → Tier 4

Each step targets a starter cell density 5–10× lower than the next vessel and is harvested at mid-late exponential phase (the “sweet-spot” for inoculum vigour — actively dividing, low senescence, low lag-time on transfer). The cascade is designed so that a fresh WCB ampoule can repopulate the entire facility within 35–42 days from thaw to first outdoor-tank harvest.

Tier 1 · Lab

10–250 mL

Erlenmeyer flask · orbital shaker · 25 °C · cool-white LED · 5–7 days

→

Tier 2 · Bench

1–20 L

Carboy / bubble column · sterile air + 1% CO₂ · 7 days

→

Tier 3 · Intermediate

100–500 L

Indoor airlift bioreactor · LED · 7–10 days · full sanitation between batches · existing lab asset (within current seed-prep / inoculum bench area; minor upgrades absorbed in the planned ₱2.24M Lab & QA line)

→

Tier 4 · Outdoor Seed Tank

~5 m³

Dedicated outdoor tank, partial cover · 7 days · produces inoculum for production cohort

→

Production

15 × 28 m³

All 16 outdoor tanks on rolling 21-day clean/reseed rotation (~15 simultaneously productive at any moment) · target inoculation density 0.3–0.5 g/L DW

Outdoor Tank Inoculation & Operation Tier 4

Pre-fill: tanks are washed, disinfected, then refilled with HDCU-treated process water and dosed with a defined N/P/trace-element stock solution to give the standard growth medium.
Inoculation density: 0.3–0.5 g·L⁻¹ dry weight from the seed tank, giving an effective starting OD₆₈₀ of ~0.6–0.9. This window minimises lag while leaving sufficient nutrients to support 6–8 doublings.
Monitoring cadence: dry weight + OD₆₈₀ daily; pH, DO, temperature continuous. Productivity is benchmarked daily against the 13–14 g·m⁻²·d⁻¹ steady-state target.
Harvest decision: tanks are partially harvested (~30–40% of culture volume) when cell density reaches ~1.5 g·L⁻¹ DW; the residual culture seeds the next growth cycle, giving a quasi-continuous semi-batch operation that maximises productive days per year.
Tank rotation: 15 tanks are in active production at any one time; the 16th rotates into deep-clean / re-seed cycle on a 21-day schedule.

Re-Inoculation into Indoor Pools (CCP1) Tier 5 · Critical Control Point

Re-inoculation is the operational hand-off from growth to stress, and is the single most important quality control point in the Split-System (HACCP CCP1).

Concentration: harvested outdoor culture is concentrated in the next-stage industrial centrifuge from ~1.5 g·L⁻¹ to a paste at ~80–120 g·L⁻¹ DW (a ~50–80× concentration factor). Centrifuge operating envelope (1,500–4,000 g) is selected to avoid cell damage.
Wash step: the concentrate is washed once with sterile fresh medium to remove residual outdoor-medium nutrients (especially N), so that nutrient stress can be cleanly imposed in the indoor pool.
Re-suspension: the washed paste is re-suspended in stress-formulated medium in the indoor pool to a defined cell density appropriate for the recipe — typically 1.0–2.5 g·L⁻¹ DW (higher for pigment recipes where reduced growth, higher per-cell metabolite is desired).
Stress program initiation: light, temperature, salinity, and nutrient profiles are loaded into the pool's controller per the validated recipe; programs run unattended on the LED + HVAC system.
Release criteria for the inoculum batch: cell viability ≥ 90% (Trypan-blue exclusion), microbial contamination < 1% by microscopy, free of foreign algae or grazers. Failed batches are re-grown rather than re-stressed.

Contamination & Biosecurity Protocol

Tiered cleanliness: Tier 1–3 vessels operate under aseptic technique (autoclaved medium, laminar-flow inoculation hood). Tier 4 outdoor tanks are necessarily semi-open but protected by HDCU water purification, mesh covers against insect vectors, and quarantine of any tank showing rotifer/ciliate signs.
Pilot-validated interventions: rotifer outbreaks managed by short-duration pH-shock (pH 10 for 30 min, then re-balance); ciliate outbreaks managed by brief dry-out + re-seed. Both successfully demonstrated in Months 1 and 6 without batch loss.
Documentation: per-batch records (inoculation date, source vessel ID, initial DW, daily monitoring, deviations, harvest date, downstream destination) retained ≥ 5 years per FDA requirement.

Chlorella Bioactives & Pilot Extraction Line

From Stressed Biomass to Premium Products

Chlorella vulgaris is described as a “natural biochemical factory” whose pigments, polysaccharides, proteins/peptides, and omega-3-rich lipids can be substantially concentrated under stress. The pilot targets five premium metabolite streams plus bulk powder, each with its own optimised extraction technology.

Target Product Portfolio & Market Context

Product	Key Use Cases	Global Market Size	Indicative World Price	Source
Lutein	Eye supplements, infant formula	~USD 380M	USD 800–1,800/kg	Market Analysis
Chlorophyll	Food colorant, pharma, cosmetics	~USD 260M	USD 500–1,200/kg
Polysaccharides (CGF)	Immune supplements, cosmetics	~USD 410M (2024)	USD 200–600/kg	Market Analysis
Bioactive Peptides	Sports nutrition, functional foods	USD 640M (algal/plant segment) Total bioactive peptide market across all sources ≈ USD 2.5B (2024)	USD 100–350/kg	Market Analysis
Algal Omega-3 Oils	Infant formula, pharma, supplements	~USD 1,040M (2026)	USD 200–700/kg	Market Analysis
Bulk Chlorella Powder	Tablets, powders, food fortification	~USD 450M	USD 12–25/kg

Cell Disruption — The Universal First Step Pre-Extraction

Chlorella vulgaris has a notoriously tough cell wall — a multi-layered, recalcitrant glycoprotein matrix rich in chitin-like glucosamine polymers, β-1,3-glucans and rigid microfibrils, with no sporopollenin (sporopollenin is restricted to certain desmid algae and pollen grains and is not present in C. vulgaris). No useful intracellular metabolite is recoverable at commercial yield without first disrupting this wall. The pilot uses a two-tool disruption stack:

Hydrodynamic Cavitation (HDCU repurposed for disruption). The same HDCU asset that purifies process water is run at higher pressure on harvested centrifuge concentrate. Pressure-induced micro-bubble collapse generates localised shear that fractures cell walls without thermal damage to heat-sensitive pigments — particularly critical for the lutein and chlorophyll trains. Recovery yields rise 35–60% versus undisrupted biomass for these molecules.
High-Pressure Bead Mill (next-stage as part of the extraction line). Used as a polishing step for products requiring near-complete cell rupture (peptides, polysaccharides).

The cell-disruption step is run immediately after centrifuge concentration, before solvent contact, to maximise bioactive recovery and minimise downstream solvent load.

Per-Product Extraction Trains Five Streams

Product	Primary Extraction Technology	Key Operating Window	Purification & Finishing
Lutein (carotenoid)	Mild alkaline saponification (KOH/EtOH) of disrupted biomass to liberate free lutein from its fatty-acid esters; followed by liquid-liquid extraction into food-grade ethanol or hexane.	40–50 °C, dark, N₂-blanketed (lutein is oxygen- and light-sensitive); 1–2 h saponification; 2-stage solvent extraction.	Concentration in thin-film evaporator under vacuum; crystallisation at 4 °C; food-grade silica-gel column polishing for >80% lutein purity grade; encapsulation in microcrystalline form for shelf-life.
Chlorophyll a + b	Direct solvent extraction with cold acetone or food-grade ethanol on disrupted biomass; magnesium-stable form preserved.	5–15 °C, dark, <30 min contact time to minimise pheophytin (loss of central Mg²⁺) formation.	Optional enzymatic conversion to copper-chlorophyllin for improved water solubility (food colorant grade); membrane filtration; spray-dry into food-grade powder or oil-suspension.
Polysaccharides (CGF) β-glucans, sulphated	Hot-water extraction (90–100 °C, 1–2 h) of disrupted biomass; followed by ethanol precipitation (3:1 EtOH:extract) to flocculate the polysaccharide fraction.	Time- and temperature-controlled to avoid over-degradation of bioactive long chains.	Tangential-flow ultrafiltration (10–100 kDa) to fractionate by molecular weight; freeze-dry to preserve bioactivity; QC by total carbohydrate (phenol-sulphuric) and bioassay.
Bioactive Peptides	Enzymatic hydrolysis of the protein fraction (alcalase + flavourzyme cascade) of de-pigmented biomass; controlled hydrolysis to a degree-of-hydrolysis target (~20%) that maximises ACE-inhibitor and antioxidant activity.	50 °C, pH 7.5–8.0, 4–6 h; enzymes inactivated by short heat shock (90 °C / 5 min).	Centrifugation to remove undigested residue; ultrafiltration to a target molecular-weight cut-off (1–5 kDa) for the bioactive fraction; spray-dry into water-soluble powder.
Algal Omega-3 Oils	Primary route — next-stage: hexane / ethanol solvent extraction with closed-loop solvent recovery (≥95% reuse); cost-optimised, fits within the ₱2.128M extraction-line budget. Phase 2 aspiration (reserved for a Phase 2 capex round): supercritical CO₂ extraction at 350 bar / 50 °C for solvent-free food-grade output, to be added when a follow-on capex round (USD 50–250k for a commercial SC-CO₂ skid) becomes available.	Solvent route at 40 °C with 3-stage counter-current extraction on disrupted biomass.	Winterisation (cold-precipitation of saturated triglycerides) to enrich the total ω-3 PUFA fraction (ALA-dominant for this strain); molecular distillation to concentrate ALA; antioxidant addition (mixed tocopherols); soft-gel encapsulation under N₂. (Marketed as ALA-rich algal omega-3 oil; not an EPA/DHA substitute.)
Bulk Chlorella Powder	Bypasses indoor stress and extraction entirely. The 30% of outdoor harvest reserved for bulk goes directly from centrifuge → spray-drier (180 °C inlet / 80 °C outlet).	Spray-drier optimised for ~5% residual moisture (FDA food-supplement spec).	Sieved, blended, packaged in food-grade aluminium-foil pouches with O₂ scavenger and desiccant; 24-month shelf life under cool storage.

Solvent Management & Sustainability

Closed-loop ethanol recovery by rectification column — target reuse rate ≥ 95% across batches; minimises both OPEX (solvent purchase) and emissions.
Hexane condensation & recovery for the lutein and omega-3 trains — vapour capture + chiller condensation at the extractor headspace.
SC-CO₂ recovery loop (Phase 2 only) — to be installed if and when the supercritical extraction skid is added under a follow-on capex round; not within the current next-stage scope.
Spent-biomass valorisation — de-extracted residue (still ~40% protein) routed to aquaculture / poultry feed channels rather than waste, contributing a small but real revenue line.

Pilot Extraction & Processing Line — Next-Stage Equipment

The next-stage capital programme is explicitly tied to the downstream equipment that converts enriched biomass into finished metabolite products.

Category	Equipment	Amount (₱)	% of Allocation
A. Downstream Processing	Industrial centrifuge (dewatering)	784,000	3.9%
	Industrial spray dryer (bulk powder)	1,232,000	6.2%
	Multi-stream solvent extraction line (closed-loop hexane/ethanol recovery skid + high-pressure bead mill polishing stage; SC-CO₂ deferred to Phase 2)	2,128,000	10.6%
	Filtration / evaporation / concentration (UF + thin-film evaporator)	1,680,000	8.4%
	Storage, cold chain, packaging line	1,120,000	5.6%
	Piping, instrumentation, integration	1,344,000	6.7%
	Installation & commissioning	1,232,000	6.2%
Subtotal Downstream Processing		9,520,000	47.6%

A closed-loop solvent-recovery design is anticipated, materially reducing operating cost and solvent emissions.

Analytical Lab & QA Stack ₱2.24M Next-Stage

An additional ₱2.24M funds a fully-equipped analytical laboratory enabling per-batch quantification, FDA-dossier compliance, and HACCP-aligned monitoring at every CCP:

HPLC with UV-VIS / DAD for pigments (lutein, chlorophyll, β-carotene).
GC-FID with cold-on-column injection for fatty-acid methyl-ester (FAME) profiles — critical for omega-3 product specification.
UV-VIS spectrophotometer for OD-based productivity and rapid pigment screening.
Microbiology suite — autoclave, BSC, incubator, microscope — for purity and sterility QC.
Standards, reference materials, and calibration package for all assays — required for traceable, audit-defensible release.

Commercial Logic for a Pilot Facility

Outdoor tanks provide cheap biomass; indoor pools create metabolite-rich feedstock; the extraction line monetises both base and premium tiers from the same biological inputs.
Pilot status allows real sales now while generating the technical, regulatory, and quality data required to support a future 2–5 ha commercial expansion and a licensing model for additional Philippine sites.

Commercial Rationale & Path to Scale

From Pilot Data to Commercial Cash Flow

The Pampanga site operates today as a working pilot demonstration facility. The next stage of the programme completes downstream processing, regulatory registration, and a full year of working capital — converting verified pilot performance into recurring commercial revenue, with Year-3 revenue targeted at ₱27.7M across six product streams.

Cost Structure (OPEX Breakdown)

Cost Driver	% of OPEX	Comment
Labor	~25%	8–14 staff; one shift; two technicians per stage
Electricity & utilities	~14%	Indoor LEDs & HVAC; outdoor negligible
Gasifiers feedstock	~6%	Local rice husks / wood chips, two-unit configuration
Nutrients & reagents	~12%	Some imported (FX exposure)
Extraction solvents & consumables	~11%	Closed-loop recovery planned
QC, packaging, certification, cold chain	~17%	QA fees, halal / FDA renewals
Maintenance & insurance	~15%	All-risk + business-interruption cover

Next-Stage Capital Allocation — Alignment to Commercial Milestones

Processing Equipment (₱9.52M): completes the extraction and finishing line, enabling all five metabolite streams plus bulk powder.
Lab & QA (₱2.24M): underpins product specifications, batch certificates, and regulatory submissions.
Regulatory & Market Development (₱2.24M): funds FDA registration of six products and halal certification, plus market-entry activities.
Working Capital & Contingency: ensures 12 months of stable pilot operation to generate proof-of-performance and meet commercial commitments.

Role of Pilot Data in De-Risking Commercial Projections

Outdoor biomass and indoor metabolite-concentration data substantiate the TEA assumptions used in the 5-year projections.
Reliability statistics (345 operating days, 5 days unplanned downtime, no major equipment failures) improve confidence in operating uptime and revenue predictability.
The facility already represents ₱17.13M in deployed equity assets — including 16 outdoor tanks, 20 indoor pools, two biomass gasifiers, the HDCU, and the B100-biodiesel-fuelled standby genset — indicating strong sponsor commitment and reducing execution risk.

Regulatory Strategy & Risk / HACCP Framework

Compliance & Protection

FDA Philippines Registration Roadmap

Product	FDA Class	Timeline	Budget (₱)
Bulk Chlorella Powder	Food Supplement (Class 1)	6–9 months	120,000
Lutein Extract	Food Supplement (Class 2)	9–12 months	180,000
Chlorophyll Extract	Food/Cosmetic Colorant	9–12 months	160,000
Polysaccharides (CGF)	Food Supplement (Class 2)	12 months	180,000
Bioactive Peptides	Food Supplement (Class 2)	12 months	180,000
Algal Omega-3 Oils	Food Supplement (Class 2)	12 months	180,000
Halal Certification (IDCP)	All products	3–6 months	280,000
Total Regulatory Budget			1,280,000

Sequencing prioritises early submission and approval of bulk powder (M3–M9), then staggered submissions for lutein, chlorophyll, and the remaining extracts to layer revenue streams over time.

HACCP-Style Risk & Quality Control Plan

The facility is governed by a formal HACCP-aligned program mapping the seven principles to specific unit operations in the Split-System process:

Hazard analysis: identify biological (contamination), chemical (solvent residues), and physical hazards at each step.
Critical Control Points: Re-inoculation (CCP1), stress induction (CCP2), solvent removal (CCP3), spray drying (CCP4), packaging (CCP5).
Critical limits: cell viability ≥ 90%; contamination < 1% by microscopy; moisture < 5% in finished powder. Residual-solvent limits are set per-solvent, aligned with ICH Q3C and US FDA 21 CFR §173 — n-hexane (Class 2) ≤ 290 ppm with an internal target ≤ 50 ppm; ethanol (Class 3) ≤ 5,000 ppm with an internal target ≤ 500 ppm; methanol is not used in the train.
Monitoring: per-batch microscopy, HPLC/GC assays, moisture/water-activity, visual and micro inspections.
Corrective actions: documented re-work / destroy procedures, root-cause analysis, CAPA log.
Verification: quarterly internal audits, annual external HACCP audits.
Documentation: batch records, monitoring logs, deviation and training records kept ≥ 5 years per FDA requirements.

Insurance & Risk Transfer

A comprehensive insurance program — industrial all-risk, 12-month business interruption, key-man, public liability, and product liability — further protects the project's commercial-stage exposure, particularly given the capital-intensive downstream equipment.

Location & Sustainability Logic — Pampanga & the Philippines

National Development Impact

Pampanga provides high solar irradiance, access to agricultural residues, and proximity to Manila's nutraceutical and pharmaceutical markets, making it a strong candidate for a pilot Chlorella biomanufacturing hub.

Strategic Alignment with Philippine National Development Priorities

Agricultural Modernization: transforms low-value rice husks and other residues into high-value algal ingredients via the gasifier loop.
Import Substitution: replaces imported lutein, chlorophyll, CGF, and algal oils with domestic production.
Rural Employment: 8–14 technical staff at pilot scale, with future scaling to dozens more in expanded phases.
Halal & Clean-Tech: halal-certifiable products and a fully biogenic CO₂ supply (gasifier flue gas + B100 genset exhaust) align the project with national clean-technology and green-finance priorities.

Existing Asset Base — Sponsor Equity In-Kind

Asset register reflects the operational pilot configuration, including the two biomass gasifiers, the Hydrodynamic Cavitator Unit (HDCU), the B100-biodiesel-fuelled standby genset, and the initial inoculum & seed-stock entry.

Asset	Description	Est. Value (₱)
16 Outdoor Cylindrical Tanks	Ø 6 m × 1 m; HDPE / concrete; paddlewheel; 452 m² combined	2,464,000
20 Indoor Stress-Induction Pools	3 m × 1.8 m × 0.77 m; fiberglass; 108 m² combined; LED + re-inoculation	2,800,000
2 × Biomass Gasifier Systems	Two downdraft gasifiers (~50–100 kg/h each), syngas burners, scrubbers, CO₂ distribution; redundant configuration	8,176,000
Hydrodynamic Cavitator Unit (HDCU)	Process-water purification by hydrodynamic cavitation; non-chemical, no inhibitory residue	1,200,000
150 kVA Standby Genset (B100 Biodiesel)	Genset on B100 biodiesel; ATS; backup power for indoor pools, instrumentation, gasifier controls; biogenic exhaust CO₂ recoverable	1,120,000
Water Storage & Distribution	Elevated/ground tanks, pumping, filtration, piping (feeds HDCU upstream of cultivation)	448,000
Civil Works & Site Improvements	Pads, drainage, shade structures, fencing, utility connections	784,000
Initial Inoculum & Seed Stock	Certified Chlorella vulgaris culture lines; starter nutrients; initial lab supplies	140,000
Total Existing Assets (Owner's Equity In-Kind)		17,132,000

Valuations are based on procurement records and current Philippine market prices for equivalent equipment. Construction basis (in response to third-party review): the outdoor tanks, indoor pools, civil works and water-distribution items reflect sponsor-managed local construction using HDPE / fiberglass / concrete fabricated on-site by Philippine contractors at pilot-grade specification — not turnkey GMP-grade procurement. Independent reviewers have observed that comparable GMP-grade construction would carry approximately 2–3× the unit cost; the sponsor accepts this as a fair characterisation and notes that the next-stage downstream-processing line, lab and finished-product packaging area are specified to GMP standard. Facility photographs of all assets in operational condition are available on request.

Total Asset Base

Combined with the next-stage downstream and lab equipment (₱9.52M + ₱2.24M = ₱11.76M), the total tangible asset base of the commercial-stage facility will reach ₱28.9M — establishing a substantial physical foundation for the Year-3 revenue ramp and any follow-on expansion phases.

Phase 2 Vision — The Circular Biorefinery: Closing the Loop with Azolla & Chlorella

Forward-Looking · Outside Current Capital Scope

Scope Note

This section sets out the Phase 2 expansion vision for the Pampanga pilot — a fully closed-loop “circular biorefinery” built around Azolla integration. It is presented for strategic and partner-engagement purposes; the financial, technical, and risk profile of the Phase 1 Split-System architecture as described in the rest of this brief remains the operational baseline. Phase 2 is an aspirational forward path that DM-XTechPhil intends to pursue once Phase 1 is operational and a follow-on capex round is secured.

At the DM-XTechPhil pilot site in Pampanga we are redefining microalgae cultivation by moving away from industrial dependence and toward biological synergy. By integrating the aquatic fern Azolla into our Split-System architecture, the 6 m outdoor tanks and 3 m indoor pools become a truly self-sustaining ecosystem.

1. Replacing Synthetic NPK — The Azolla Bio-Engine

In traditional algae farming, growth is fuelled by synthetic NPK fertilisers. In our closed-loop vision we replace these chemical inputs with Azolla — a living nitrogen factory.

Atmospheric nitrogen fixation: Azolla hosts the cyanobacterium Anabaena azollae, which fixes nitrogen directly from the air. By processing harvested Azolla biomass into a stabilised liquid extract, we supply our Chlorella vulgaris cultures with biologically-derived nitrogen, phosphorus, and potassium — eliminating the need for synthetic urea or ammonium nitrate.
Cost & carbon benefit: Insulates the project from global fertiliser price spikes and removes the embedded carbon footprint of industrial NPK manufacture.
Halal & organic alignment: Because all macronutrients are derived from purely biological sources, the resulting Chlorella streams strengthen halal-compliance and open a credible pathway to organic certification for export buyers requiring the higher tier.
Footprint & N mass-balance (revised in response to third-party review): a transparent calculation supersedes the earlier indicative figure. Chlorella N-demand at Phase-1 throughput (2,011 kg DW/yr × 8% N) ≈ 161 kg N/yr; at Phase-2 commercial throughput (~6,500 kg DW/yr) ≈ 520 kg N/yr. Median Azolla N-supply, using 70 kg FW·m⁻²·yr⁻¹ × 6% DW × 5% N ≈ 0.21 kg N·m⁻²·yr⁻¹. The implied Azolla pond footprint is therefore ~770 m² for Phase 1 (≈ 1.7× the 452 m² Chlorella outdoor area) and ~2,500 m² for Phase-2 commercial throughput (≈ 5.5× the outdoor area) — substantially larger than earlier indicative scoping. Validating this mass-balance via a side-by-side Azolla-fed vs synthetic-NPK-fed Chlorella trial is therefore a prerequisite for any commercial Phase-2 nitrogen-replacement claim, and is sized into the Year 2–3 transition activities below.

2. Water Stewardship — Mechanical, Not Chemical

The HDCU's water-purification role (already in operation in Phase 1) is reframed under the Phase 2 circular vision as the mechanical alternative to chemical disinfection:

Mechanical sterilisation: Pressure-induced micro-bubble collapse mechanically disrupts the cell walls of incoming contaminants — rotifers, wild bacteria, protozoa — without adding a single drop of chlorine or other residue-leaving disinfectant.
A clean slate: Water entering the 28,000-litre outdoor tanks is biologically “silent,” allowing the qualified Chlorella strain to dominate the culture area from day one. Together with the Azolla nutrient stream, this completes the closed inorganic-input loop.

3. The Split-System Reframed — Grow Cheap, Enrich Expensive, Waste Nothing

Stage 1 — Outdoor Bulk Cultivation (the “green field”)

Sixteen 6 m × 1 m tanks harness intense Philippine sun for bulk biomass production. CO₂ comes from the on-site biomass gasifiers (rice-husk feedstock) and the B100-biodiesel genset exhaust. Average pilot productivity: 12.9 g·m⁻²·d⁻¹. Under Phase 2, nitrogen comes from the Azolla extract loop — closing the macronutrient cycle.

Stage 2 — Indoor Stress Induction (the “precision lab”)

Twenty 3 m × 1.8 m indoor pools don't grow more algae — they make existing algae better. By withdrawing the Azolla-derived nitrogen and applying programmable LED light and temperature cycling, the cells are “tricked” into concentrating high-value molecules: lutein, omega-3s, CGF, bioactive peptides.

4. Why This Matters for the Philippines

Phase 2 elevates the Pampanga site from an algae farm into a Circular Biomanufacturing Hub. Local agricultural residues (rice husks) supply the carbon, local aquatic plants (Azolla) supply the nutrients, and de-extracted biomass returns to the local community as high-protein aquaculture and poultry feed. The result is a system that is:

Resilient

Input-Independent

Immune to global fertiliser & CO₂ price shocks

Sustainable

Zero-Waste

Spent biomass → aquaculture & poultry feed

Sovereign

Made in PH

Replaces imported nutraceutical ingredients

Implementation Pathway (Phase 2)

Years 1–2 (Phase 1): commission the next-stage downstream + lab equipment, complete FDA/halal registration, build the 12-month operating dataset on the existing Split-System.
Year 2–3 (transition): stand up a dedicated Azolla pond array (~10–20% of outdoor footprint), build the Azolla-extract processing skid (mechanical pulping, anaerobic stabilisation, micro-filtration), and run side-by-side trials of Azolla-fed vs synthetic-NPK-fed Chlorella to quantify yield, cost, and metabolite-profile equivalence.
Year 3+ (Phase 2 scale-out): phase out synthetic NPK, scale the Azolla loop to full demand, secure organic certification, and pursue the SC-CO₂ extraction skid + further downstream extensions under a follow-on capex round.

This Phase 2 vision is forward-looking and does not modify the Phase 1 Split-System architecture, the assumptions in the 12-month pilot dataset, or the financial projections set out in the project documentation. It is shared to give technical reviewers, partners, and follow-on investors visibility on the project's long-term direction.

Conclusion & Next Steps

From Pilot to Full-Scale Biomanufacturing

The Pampanga Split-System Chlorella Biorefinery is already functioning as a pilot demonstration plant, generating real biomass, real metabolites, and real operating data. The next stage of the programme completes the processing, QA, and regulatory stack required to fully monetise an existing, de-risked asset base of ₱17.1M and to advance the long-term Phase 2 vision of a fully closed-loop circular biorefinery.

Key Project Merits

Technically validated: 12-month productivity and metabolite data substantiate the TEA assumptions underpinning the 5-year operating model.
Innovative yet simple architecture: Split-System “grow cheap, enrich expensive” isolates energy-intensive stress and extraction steps, materially improving unit economics versus all-indoor photobioreactor designs.
Strategic market positioning: direct access to domestic nutraceutical, food, aquaculture, and cosmetic markets currently dependent on imports.
Regulatory and risk framework in place: detailed FDA roadmap, halal plan, HACCP program, and insurance coverage.
Scalable platform: pilot data and know-how are explicitly designed to underpin Phase 2 expansions (2–5 ha), the Azolla-integrated circular biorefinery, and licensing to other regions of the Philippines.

Next Step Recommendations

Finalise and implement detailed SOPs for propagation, re-inoculation, and stress protocols using the pilot Q1–Q4 learning curve.
Commission the next-stage extraction and lab equipment in a phased manner, synchronised with FDA submission timelines and early customer contracts.
Use pilot batch data and HACCP records to engage key nutraceutical and pharmaceutical buyers for supply agreements that anchor premium-tier revenue.
Develop a scale-up and licensing prospectus based on pilot operating metrics to position DM-XTechPhil as the reference partner for Chlorella biomanufacturing in the Philippines.

About This Document

This Pilot Demonstration Brief summarises the technical, scientific, and commercial profile of the DM-XTechPhil Split-System Chlorella Biorefinery in Pampanga, Philippines, together with its long-term Phase 2 circular-biorefinery vision. It is intended for technical reviewers, research collaborators, partners, and prospective offtake or follow-on investors. All figures and operational data reflect the 12-month pilot operating dataset.

References

Selected peer-reviewed literature supporting the Split-System architecture, stress-induction strategy, and downstream-processing design described in this brief. DM-XTechPhil internal pilot data and engineering files are available to qualified reviewers under separate cover.

Bhalamurugan G.L., Valerie O., Mark L. (2018). Valuable bioproducts obtained from microalgal biomass and their commercial applications: A review. Environmental Engineering Research, 23(3), 229–241. — supports carotenogenesis under high-light stress.
Hu Q., Sommerfeld M., Jarvis E., Ghirardi M., Posewitz M., Seibert M., Darzins A. (2008). Microalgal triacylglycerols as feedstocks for biofuel production: perspectives and advances. The Plant Journal, 54(4), 621–639. — supports lipid accumulation under nitrogen starvation.
Solovchenko A.E. (2012). Physiological role of neoxanthin and its biosynthesis under stress in green microalgae. Russian Journal of Plant Physiology, 59(2), 167–176. — supports stress-induced secondary carotenoid biochemistry.
Lee I., Han J.-I. (2015). Simultaneous treatment (cell disruption and lipid extraction) of wet microalgae using hydrodynamic cavitation. Bioresource Technology, 186, 246–251. — supports HDCU cell-disruption yield uplift and solvent-route extraction.
Khanra S., Mondal M., Halder G., Tiwari O.N., Gayen K., Bhowmick T.K. (2018). Downstream processing of microalgae for pigments, protein and carbohydrate in industrial application: A review. Food and Bioproducts Processing, 110, 60–84. — supports the multi-product downstream architecture.
Wagner H. et al. (2010 onward, peer-reviewed reviews). Azolla–Anabaena symbiosis as a sustainable nitrogen biofertiliser. — supporting reference for the Phase 2 Azolla bio-engine concept.